Plasmid DNA Manufacturing Market Size Is Projected To Reach USD 5,899.5 Million By 2030Posted by Neha Bora on August 4th, 2023 San Francisco, 4 Aug 2023: The Report Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Disease (Cancer, Infectious Diseases), By Grade (R&D, GMP), By Application, By Development Phase, And Segment Forecasts, 2023 - 2030 The global plasmid DNA manufacturing market size is expected to reach USD 5,899.5 million by 2030, registering a CAGR of 17.63% over the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases, combined with the wide application scope of plasmid DNA in the healthcare industry is expected to drive the industry growth. Plasmid DNA can be used directly for therapeutic applications, such as the production of vaccine antigens or gene therapy. Moreover, it can be utilized for various research purposes, such as gene cloning, gene mapping, etc. The rising number of patients choosing gene therapy is expected to drive industry growth in the coming years. According to clinicaltrials.gov, the number of cell & gene therapies across global pipeline programs (Phase I to Phase III trials) increased from 289 in 2018 to 327 in 2022. Furthermore, the U.S. FDA provides constant support for innovations in the advanced therapy arena via several policies concerning product manufacturing. With increased cell and gene therapy products, the industry will see an increased need for manufacturing plasmid DNA on a larger scale. The COVID-19 pandemic is anticipated to positively impact industry growth. For instance, in September 2021, India approved the first COVID-19 DNA vaccine. It is the world’s first COVID-19 DNA vaccine manufactured in partnership with DBT-BIRAC as part of Mission COVID Suraksha. Circular DNA is used in India’s ZyCoV-D vaccination to protect against COVID-19 infection. Furthermore, key entities in the global industry are undertaking various strategic initiatives to strengthen their market presence, which is also expected to propel growth. For instance, in June 2022, BioCina announced the expansion of the production of plasmid DNA in a new dedicated GMP suite to its offering of CDMO services. The suite has a single-use fermentation capacity of up to 300 L and appropriately scaled downstream processing machinery. Access Research Report of Plasmid DNA Manufacturing Market @ https://www.grandviewresearch.com/industry-analysis/plasmid-dna-manufacturing-market-report Plasmid DNA Manufacturing Market Report Highlights
Plasmid DNA Manufacturing Market Report Scope
List of Key Players of Plasmid DNA Manufacturing Market
Access Press Release of Plasmid DNA Manufacturing Market @ https://www.grandviewresearch.com/press-release/global-plasmid-dna-manufacturing-market Like it? Share it!More by this author |